Home / About us
About us: Small molecule drug discovery and development services – from ID to IND.
Move from inception to IND openly, quickly and expertly with your integrated CRO and CDMO partner
Our knowledge, your success
Experience matters to deliver faster, clearer decisions with fewer risks. At Symeres, knowledge means knowing how to adapt fast and communicate transparently, all without losing scientific depth to power your next breakthrough.
Connected science
Chemistry, biology, CMC, ADME-tox and scale up, all connected under one approach – fewer handoffs, fewer errors, faster path to success.
Continuity that counts
Dedicated, expert scientists stay on your program, so progress builds without costly resets.
Open by design
Clear communication, shared data and direct ownership across sites keeping you informed and on your project track
Nimble in delivery
When priorities, funding or data change we proactively re-plan, so work never stands still
We make early-stage drug projects real
Drug development can be unpredictable, so we built an approach that keeps your program visible, adaptable and scientifically sound from day one.
Our teams work across medicinal chemistry, in vitro biology, ADME-tox, and process chemistry, all connected through shared leadership and data systems – so you’ll always know what works, what doesn’t and what to do next.
Quality built in
Timelines can slip when data is unclear, vendors are disconnected, or methods fail to scale. We keep discovery, development, and manufacturing tightly connected to prevent rework and keep your IND timeline intact.
Results are shared quickly, even when they are unexpected, so you can adapt and keep progress on track.
Our leadership team
Senior scientists lead your program from first compounds through to clinical supply
European and US teams are aligned under shared systems, avoiding duplication and communication gaps
Cross-discipline expertise lets us anticipate potential problems early to prevent stalled timelines and wasted spend
Direct contact with leadership means faster answers, clearer priorities and no message filtering
Our transatlantic presence
With labs and GMP manufacturing facilities in the Netherlands, Finland, Czech Republic, the US and other European sites, you get local access with global delivery.
This translates to real-time collaboration, better regulatory alignment and smoother projects across time zones. Our transatlantic advantage combines with unparalleled scientific rigor to get your next breakthrough achieved wherever you are globally.
What do our partners say?
“A sign that things are going well - we keep coming to you. We’ve given Symeres five or six different projects already. That’s almost unheard of for us.“
Senior Director, Manufacturing
Top 10 global pharma
“The progression was really phenomenal. I am truly impressed. There is a world of difference between you and other CROs.”
Start-up Founder
Biotech
“If the compound can be made, Symeres will undoubtedly find out a good way to make it.”
Dooyoung Jung, CEO
Pinotbio
“They’ve always met or exceeded my expectations - that’s why I continue to come back, company after company, year after year.”
Allen Horhota, Vice-President Platform & Delivery
Seamless Therapeutics
“The team is making short work of these targets, so we will have to start thinking of some additional targets!”
Director
Biotech
“I would like to extend my thanks for the excellent work Symeres has done in synthesizing the API for Part 1 of our project. Your communication throughout the process was outstanding, and the sense of urgency with which you operated allowed us to complete this phase promptly and efficiently.”
Leader
Large biotech
“We are developing the most complex molecule that is built at this time in the world…We work with a lot of CROs, also chemistry CROs, and so far Symeres has done the best job with respect to transparency and also to troubleshoot the problems and find a solution. Over the years we have been really impressed with the work that Symeres has done.”
Founder
Biotech
“Through our dedicated FTE resource at Symeres we have achieved remarkable results, not only by developing a new “aspirational” synthetic route but also by significantly improving the current one to deliver a sustainable route for commercial production and giving us two options for late development.”
Associate Director
Large pharma, Europe
“We’ve been with them…over 10 years. The cost, the flexibility - the value is just so strong. That’s why we’ve stuck with them.”
Senior Director, CMC
Biotech
Your drug discovery and development partner
Openness keeps you informed. Nimbleness keeps you moving. Expertise keeps decisions grounded in science. That’s how we help global biotech and pharma teams move through uncertainty: efficiently, transparently and with scientific rigor you can depend on.
Speak with our experts
Let’s discuss how Symeres can support the discovery and development of your next breakthrough.